Biotech

All Articles

Repare lays off 25% of staff as biotech standstills preclinical R&ampD

.Repare Therapeutics is actually laying off an one-fourth of its own labor force as the oncology bio...

J &amp J files for FDA confirmation of $6.5 B autoimmune medication

.Johnson &amp Johnson has taken another measure towards noticing a yield on its $6.5 billion nipocal...

Gain's stage 1 win paves way to confirm Parkinson's medicine's worth

.Gain Therapeutics has established its own sights on showing the performance of its own Parkinson's ...

Actinogen records brand new period 2 data to salvage anxiety medicine

.Actinogen Medical's chances-- and also stock price-- have recoiled somewhat from earlier this month...

Pfizer as well as Flagship incorporate Quotient to multibillion-dollar equation

.Front Runner Pioneering and also Pfizer have included Quotient in to their 10-program relationship,...

Bayer markers $547M treaty to drive limits of noncoding RNA

.Bayer executives were eager to anxiety to Fierce this summer months that the German pharma giant's ...

UK introduces programs to launch 18 brand new medical trial centers

.Surrounded by a yearslong clinical trial decline in the U.K., a new public-private relationship has...

UPDATE: Genentech telegrams 93 layoffs in The golden state after discussing programs to shutter cancer immunology research unit

.Complying with the announcement of a huge unemployment shot in April and a major restructuring camp...

Neurocrine's KarXT rival attacks in stage 2-- yet only at reduced dosage

.Neurocrine Biosciences has actually accomplished its hoped-for account in a period 2 schizophrenia ...

Vaderis' unusual blood vessel disorder medication decreases nosebleeds

.Vaderis Rehabs' objective to cultivate the 1st drug targeted exclusively at a certain unusual capil...